Triple gastrointestinal prophylactic therapy following high-power short-duration posterior left atrial wall ablation

The purpose of this study is to investigate incidence of gastrointestinal symptoms and complications in patients who underwent high-power short-duration (HPSD), posterior left atrial wall isolation during atrial fibrillation ablation and thereafter have received gastrointestinal prophylactic regimen...

Full description

Saved in:
Bibliographic Details
Published in:Indian heart journal 2020-07, Vol.72 (4), p.306-308
Main Authors: Candemir, Basar, Baskovski, Emir, Mammadov, Mammad, Esenboga, Kerim, Altin, Timucin
Format: Article
Language:English
Subjects:
Atrial fibrillation
Catheter ablation
Complication
Proton-pump inhibitor
Research Brief
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The purpose of this study is to investigate incidence of gastrointestinal symptoms and complications in patients who underwent high-power short-duration (HPSD), posterior left atrial wall isolation during atrial fibrillation ablation and thereafter have received gastrointestinal prophylactic regimen consisting of sucralfate, proton-pump inhibitor and colchicine. Patients were followed and assessed at baseline, up until 6th month following the procedures.Among 115 patients who were included, 5 patients (4.3%) reported gastrointestinal symptoms at follow-up. No complications were diagnosed during the follow-up. In conclusion, the HPSD along with prophylactic regimen has been associated with low incidence of gastrointestinal adverse events.
ISSN:0019-4832
2213-3763
DOI:10.1016/j.ihj.2020.06.007